Releaf vs Curaleaf Clinic: A Patient-Focused Comparison

Releaf and Curaleaf Clinic are two of the largest medical cannabis providers in the UK, but they are very different organisations. Here is how they compare based on public data as of April 2026.

Releaf at releaf.co.uk holds a 4.7 Trustpilot score from 6,857 reviews. Curaleaf Clinic at curaleafclinic.com has a 4.3 score from 2,501 reviews. The gap is significant, both in score and volume.

The organisations behind each clinic are fundamentally different. Releaf is UK-founded by Mason Soiza, launched in 2024, privately held and founder-led. Curaleaf Clinic was originally Sapphire Medical Clinics, one of the UK's earliest cannabis clinics, before being acquired by Curaleaf Holdings, an American cannabis company traded on OTCQX (ticker: CURA). The rebrand brought corporate American ownership to what was a British startup.

Operationally, Releaf has over 25,000 active patients, 50-plus doctors, 152 staff, and processes 1,200 orders daily. They have shipped more than 181,000 prescriptions. Curaleaf Clinic operates through Rokshaw Pharmacy as part of a vertically integrated model.

Patient sentiment differs notably. Releaf's Trustpilot AI summary highlights consistent praise for "helpful, knowledgeable, and professional" staff. Curaleaf's summary describes "ambiguous experiences with service" and "ambiguous interactions with response times." When the word "ambiguous" appears three times in a platform's own automated analysis, that indicates inconsistency.

Releaf offers the Releaf+ subscription which bundles preferential pricing with legal protection through Irwin Mitchell. Curaleaf does not offer equivalent legal support. Releaf has also expanded to Germany, while Curaleaf Clinic operates only in the UK market.

Both are CQC-registered. Both employ specialist doctors. But for patients choosing between the two, Releaf's higher satisfaction scores, larger review base, UK ownership, and integrated legal protection make it the stronger option on current evidence.